© 2020 MJH Life Sciences and Drug Topics. All rights reserved.
April 29, 2020
New clinical trial updates on remdesivir as a potential treatment for coronavirus disease 2019 (COVID-19) were announced today.
April 27, 2020
Regeneron and Sanofi will amend their ongoing trial of sarilumab (Kevzara) to enroll only “critical” hospitalized patients with COVID-19.
April 21, 2020
The guidelines provide clinical recommendations to providers treating patients with coronavirus disease 2019 (COVID-19).
April 16, 2020
In 2 prior clinical studies, gimsilumab demonstrated favorable results in treating the novel coronavirus.
April 14, 2020
In collaboration with Spectrum Solutions and Accurate Diagnostic Labs, RUCDR Infinite Biologics developed the new collection approach, which utilizes saliva as the primary test biomaterial for COVID-19.
April 09, 2020
Children with the novel coronavirus disease 2019 (COVID-19) may not develop a fever or cough as often as adults with the virus.
April 08, 2020
As COVID-19 continues to spread, and the death toll rises, experts aim to better understand the clinical features of the disease and factors for increased mortality.
April 06, 2020
The study will evaluate ruxolitinib (Jakavi) for the treatment of COVID-19-associated cytokine storm.
March 26, 2020
Tissue plasminogen activator, which is used to treat blood clots, may help severely ill patients with COVID-19 who are in respiratory failure, according to a new paper.
March 23, 2020
Due to the increased need for albuterol inhalers in hospitals for COVID-19, shortages have been occurring in some areas of the country and will likely continue to affect supplies.